CDC authorizes COVID-19 vaccines for children 5-11 years of age

Image of GettyImages-1315887649.jpg

Key Takeaways

On November 2, the Centers for Disease Control and Prevention (CDC) approved the use of COVID-19 vaccines for children aged 5-11 following the Food and Drug Administration’s (FDA) recommendation. The CDC’s endorsement follows the FDA’s recommendation on October 29 to authorize emergency use of the Pfizer-BioNTech COVID-19 vaccine to include children 5-11 years of age.

The FDA’s decision comes after it was determined the vaccine was approximately 91 percent effective in preventing COVID-19 in children 5-11 years of age. Children within this age group account for 39 percent of COVID-19 cases in individuals younger than 18 years of age across the nation. An ongoing study discovered no serious side effects in approximately 3,100 children aged 5-11 who received the COVID-19 vaccine.

On October 14, the CDC released a Pediatric COVID-19 Vaccination Operational Planning Guide, which highlights key differences between adult and adolescent vaccination programs and those that are designed for children. The National Association of County and City Health Officials (NACCHO) has provided a summary of the guide and pulled out high-level considerations for county health departments, as key components of pediatric COVID-19 vaccination planning in local communities.

As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported over 192 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters. For more information on how county health facilities can prepare for the distribution of COVID-19 vaccines for children, and COVID-19 boosters, see NACo’s COVID-19 Vaccine Distribution Toolkit.

ADDITIONAL RESOURCES

Tagged In:

Related News

Jason Berry (center), director of planning and community engagement in Monroe County, Mich., advises how to evaluate the impact of opioid settlement investments with Marcus Boyd (right), opioid settlement program manager, Mecklenburg County, N.C., in a discussion moderated by Amy Dolinky, director of opioid services, Michigan Association of Counties. Photo by Mary Ann Barton
County News

Counties turn to universities, hard data to gauge opioid settlement impact

Evaluating the efficacy programming is often the hardest and most neglected piece of allocating opioid settlement funds.

McLeanEMS
County News

County offers leave for EMS volunteers

Facing challenges that could further shrink its pool of EMS volunteers, McLean County, N.D. eased the process for county staff to participate.